New publication - Attana’s technology was used to optimize affinity and efficacy of an antibody fragment for treatment of inflammatory diseases
A new paper has been published in mAbs by Prof. Konterman and co-workers at University of Stuttgart. This work is in the same project as the recent publication .The aim of this study was to extended serum half-life, increase affinity and improved efficacy. Attana's QCM technology was used to optimize the specific interaction properties of the antibody